Page 1 of 2
Material Safety Data Sheet (MSDS)
For ImmuBlot Anti-MAG Western Blot Kit #1173
ImmuBlot Anti-Neuronal Western Blot Kit #1174
Positive Control (Catalog #2207, 2208)
IMMCO Diagnostics, Inc. Negative Control (Catalog #2218)
60 Pineview Drive Serum Diluent (Catalog #2309)
Amherst, NY 14228 Conjugate A (Catalog #2133)
(Phone) 716-691-0091 - 800-537-8378 Conjugate B (Catalog #2119)
(Fax) 716-691-0466 Conjugate M (Catalog #2132)
Enzyme Substrate (Catalog #2512)
MSDS Number: M1027K
Date Prepared: 3-5-03
Prepared by: ______________________________
*The statements contained herein are offered for informational purposes only and are intended to be followed only by persons having
related technical skills and at their own discretion and risk. Since conditions and manner of use are outside our control we make no
warranties, express or implied, and assume no liability in connective with use of this information.
Note: Physical and health hazard information on reagent mixtures have not been determined. Any physical and health information
noted is based on evaluation of data from the pure ingredients.
SECTION 1 鈥? MATERIAL IDENTIFICATION AND INFORMATION
Components 鈥? Chemical Name & Common Names % OSHA ACGIH Other Limits
(Hazardous Components 1% of greater; Carcinogens 0.1% or PEL TLV Recommended
greater)
Human Serum Varies NA NA NA
0.3mg/m3
SODIUM AZIDE <0.1% NA NA
SECTION 2 鈥? PHYSICAL/CHEMICAL CHARACTERISTICS
Boiling Point NA Specific Gravity (H2O = 1) NA
Vapor Pressure NA Melting Point NA
(mm Hg and Temperature)
Vapor Density (Air = 1) NA Evaporation Rate (butyl acetate = 1) NA
Solubility in Water NA Water Reactive NA
Appearance and Odor: Clear, colorless to slightly yellow liquid, no odor.
SECTION 3 鈥? FIRE AND EXPLOSION HAZARD DATA
Flash Point and Auto-Ignition Flammability Limits in Air % LEL UEL
Method Used NA Temperature NA by Volume NA NA NA
Extinguisher Media: normal extinguishing materials
Special Fire Fighting Procedures: none known
Unusual Fire and Explosion Hazards: none known
M1027K Page 2 of 2
SECTION 4 鈥? REACTIVITY HAZARD DATA
STABILITY Conditions to Avoid
__X_ Stable None known
____ Unstable
Incompatibility (Materials to Avoid) None
Hazardous
Decomposition Products None
Conditions to Avoid
HAZARD POLYMERIZATION
____ May Occur None known
_X__ Will Not Occur
SECTION 5 鈥? HEALTH HAZARD DATA
PRIMARY ROUTES OF ENTRY CARCINOGEN LISTED IN
___ Inhalation _X_ Ingestion ___ NTP ___ OSHA
_X_ Skin Absorption ___ Not Hazardous ___ IARC Monograph _X_ Not Listed
Acute: None known
HEALTH HAZARDS
Chronic: None known
Signs and Symptoms of Exposure: None known
Medical Conditions Generally Aggravated by Exposure: None known
Emergency First Aid Procedures 鈥? Seek medical assistance for further treatment, observation and support if necessary.
Eye Contact : flush with copious amounts of water for 15 minutes; contact a physician
Skin Contact: wash with germicidal soap and water for at least 15 minutes
Inhalation: move to fresh air; contact a physician
Ingestion: contact a physician
SECTION 6 鈥? CONTROL AND PROTECTIVE MEASURES
Respiratory Protection (Specify Type) NA
Protective Clothing: gloves Eye Protection: safety goggles
___ Local Exhaust ____ Mechanical (general) ____ Special
VENTILATION TO BE
USED NA
___ Other (specify)
Other Protective Clothing and Equipment: NA
Hygienic Work Practices: NA
SECTION 7 鈥? PRECAUTIONS FOR SAFE HANDLING AND USE / LEAK PROCEDURES
Steps to be Taken if Material is Absorb spill with nonreactive material (such as vermiculite, dry sand, etc.). Clean
Spilled or Released area with household bleach and paper towels.
Waste Disposal Methods Dispose in accordance with practices employed for infectious waste. WARNING
鈥? Sodium azide may react with lead and copper plumbing to form highly explosive
metal azides. Upon disposal of liquids, flush with large volumes of water to
prevent azide buildup
Precautions to be Taken in Keep refrigerated at 2掳 - 8掳C.
Handling and Storage
All human derived components have been tested and found to be negative for HBsAg and for antibodies to HIV by FDA required tests.
However, all human serum specimens and human derived products should be treated as potentially hazardous, regardless of their
origin. Follow good laboratory practices in storing, dispensing, and disposing of these materials as per Biosafety in Microbiological and
Biomedical Laboratories. Centers for Disease Control, National Institutes of Health, 1993 (HHS Pub. No. [CDC] 93-8395).
|